Ideaya Biosciences (IDYA) PT Lowered to $20 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street slides as AI cash burn worries spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil prices set for fourth straight monthly gains as tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Price: $31.94 -2.89%
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 48 | New: 9
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 48 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler lowered the price target on Ideaya Biosciences (NASDAQ: IDYA) to $20.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $875 at Baird
- Boot Barn (BOOT) PT Lowered to $175 at Jefferies, 'We recommend buying BOOT'
- Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens - Doctor Feedback for Darovasertib Positive
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
